India is battling a silent but deadly epidemic — the spread of counterfeit medicines and consumer goods. The recent cough syrup tragedy has forced an in-depth investigation, exposing deep weaknesses within the regulatory system. Between 2023 and 2025, multiple incidents of fake or contaminated drugs were discovered, yet most culprits faced little or no punishment.